Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism

Dewailly, Didier; Catteau-Jonard, Sophie; Reyss, Anne-Céline; Leroy, Maryse; Pigny, Pascal

doi:10.1210/jc.2006-1054

Cited by 198Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsEndometriosis Research and Treatment

Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism

Dewailly, Didier, Catteau-Jonard, Sophie, Reyss, Anne-Céline, Leroy, Maryse, Pigny, Pascal·2006·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2006-1054

Open this paper in CoChat — free account

Abstract

OBJECTIVES: By requiring a minimum of two of three items [hyperandrogenism (HA), oligoanovulation (OA), and polycystic ovaries (PCO) at ultrasound], the Rotterdam definition recognizes four PCO syndrome (PCOS) phenotypes: HA+OA+PCO (full-blown syndrome), HA+OA (former National Institutes of Health definition), HA+PCO (ovulatory PCOS), and OA+PCO. However, the latter phenotype is controversial, and it is not known to what extent it shares similarities with the others. DESIGN: The study was a comparative analysis of hormonal, metabolic, and ultrasound parameters obtained from patients and controls that were consecutively included in a database. PATIENTS AND METHODS: Sixty-six patients having OA+PCO without hirsutism or elevated serum androstenedione and testosterone levels were compared with 118 normally cycling nonhyperandrogenic age-matched women without PCO (controls). These patients (phenotype D) were also compared with patients with HA+OA+PCO (phenotype A, n = 246), HA+OA (phenotype B, n = 27), and HA+PCO (phenotype C, n = 67). RESULTS: Patients with phenotype D had higher mean values of waist circumference and higher mean levels of serum testosterone, androstenedione, and LH than controls. Conversely, they had lower mean serum levels of FSH and SHBG (P < 0.05 for each parameter). Variance analysis disclosed significant group effects between the different patients' phenotypes for all parameters, except age, BMI, and FSH. After multiple comparisons with post hoc analysis, phenotype D had milder endocrine and metabolic abnormalities than phenotype A, although it did not differ from phenotype C, except for androgen data, by definition. Phenotypes A and B were statistically similar, except for the ultrasound data, by definition. CONCLUSION: Oligoanovulatory patients with PCO but without HA have mild endocrine and metabolic features of PCOS.

Integrity signals

Registry

Crossref · 10.1210/jc.2006-1054

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Most studies have used inaccurate measures of IR.
“However, most studies have used inaccurate measures of IR (Dewailly et al., 2006;Barber et al., 2007;Panidis et al., 2012).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Dewailly et al., 2006

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works
Men at risk: occupation and male infertility.
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219 · see citing works
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015 · see citing works
Self-citation
MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE
Adams, J., POLSON, D. W., Abdulwahid, N. A., Morris, D. V., Franks, S., Mason, H. D., Tucker, M., Price, J., & Jacobs, H. S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92552-8 · Cited by 791 · see citing works
Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest
Pigny, P., Merlen, E., Robert, Y., Cortet-Rudelli, C., Decanter, C., Jonard, S., & Dewailly, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030727 · Cited by 709 · see citing works
Self-citation
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703 · see citing works
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life Span
Azziz, R., Marin, C., Hoq, L., Badamgarav, E., & Song, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0628 · Cited by 537 · see citing works
Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature
Azziz, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2153 · Cited by 434 · see citing works
Ultrasound examination of polycystic ovaries: is it worth counting the follicles?
Jonard, S. (2003) · Human Reproduction · doi:10.1093/humrep/deg115 · Cited by 367 · see citing works
Diagnosis of Polycystic Ovarian Syndrome: In Defense of the Rotterdam Criteria
Franks, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2501 · Cited by 278 · see citing works
Clinical review 56: Nonclassic adrenal hyperplasia: current concepts
Azziz, R., Dewailly, D., & Owerbach, D. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.4.8157702 · Cited by 275 · see citing works
Self-citation
Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters
Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2279 · Cited by 274 · see citing works
Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin
PUGEAT, M. M., Crave, J. C., Elmidani, M., Nicolas, M. H., Garoscio-Cholet, M., Lejeune, H., Déchaud, H., & TOURNIAIRE, J. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90310-2 · Cited by 214 · see citing works
Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome
van Santbrink, E. J. P., Hop, W. C. J., & Fauser, B. C. J. M. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)80068-4 · Cited by 187 · see citing works
Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian Syndrome
Adams, J. M., Taylor, A. E., Crowley, W. F., & Hall, J. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031600 · Cited by 179 · see citing works
Diagnostic criteria for polycystic ovary syndrome: A reappraisal
Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.01.085 · Cited by 172 · see citing works
Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries
Jonard, S. C., Robert, Y., & Dewailly, D. (2005) · Human Reproduction · doi:10.1093/humrep/dei159 · Cited by 159 · see citing works
Self-citation
Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight
Michelmore, K. F., Ong, K. K., MASON, S. A., Bennett, S. T., Perry, L., Vessey, M. P., Balen, A. H., & Dunger, D. B. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01375.x · Cited by 112 · see citing works
Androgen excess is the key element in polycystic ovary syndrome
Azziz, R. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00735-0 · Cited by 109 · see citing works
Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin
Couzinet, B., Young, J., Brailly, S., Bouc, Y. L., Chanson, P., & SCHAISON, G. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00649.x · Cited by 106 · see citing works
Polycystic ovaries in hirsute women with normal menses
Carmina, E., & Løbo, R. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00979-2 · Cited by 101 · see citing works
Do hyperandrogenic women with normal menses have polycystic ovary syndrome?
Carmina, E., & Løbo, R. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00455-5 · Cited by 100 · see citing works
Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
Taponen, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh214 · Cited by 90 · see citing works
Endocrinology: Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome
Norman, R. J., Hague, W. M., Masters, S. C., & Wang, X. J. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136280 · Cited by 85 · see citing works
Polycystic ovarian morphology and bulimia nervosa: a 9-year follow-up study
Morgan, J. F., McCluskey, S. E., Brunton, J. N., & Hubert Lacey, J. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03063-7 · Cited by 79 · see citing works
Ultrasonographic study of ovaries of 19 women with weight loss-related hypothalamic oligo-amenorrhea.
Futterweit, W., Hc, Y., & Ji, M. (1988) · PubMed · Cited by 28 · see citing works
Clinical review 77: evaluation of secondary amenorrhea.
Warren, M. P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636244 · Cited by 27 · see citing works
Clinical and laboratory characteristics of adolescents with both polycystic ovary disease and anorexia nervosa
Pinhas‐Hamiel, O., Pilpel, N., Carel, C. A., & Singer, S. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.11.041 · Cited by 20 · see citing works
Are there differences in ultrasound parameters between Chinese women with polycystic ovaries only and with polycystic ovary syndrome?
Ng, E. H. Y., Chan, C. C. W., & Ho, P. C. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.07.023 · Cited by 19 · see citing works
How many of the items in the polycystic ovary syndrome can be validated statistically?
Dewailly, D. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.11.001 · Cited by 5 · see citing works
Self-citation

Flagged first, then by citations

Sorted by citations

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · see citing works
Self-citation
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · see citing works
Self-citation
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · see citing works
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · see citing works
Polycystic ovary syndrome
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005 · see citing works
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · see citing works
Polycystic ovary syndrome
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360 · see citing works
Self-citation
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · see citing works
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010 · see citing works
Polycystic ovary syndrome
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 802 · see citing works
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747 · see citing works
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581 · see citing works
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries
Dewailly, D., Gronier, H., Poncelet, É., Robin, G., Leroy, M., Pigny, P., Duhamel, A., & Catteau-Jonard, S. (2011) · Human Reproduction · doi:10.1093/humrep/der297 · Cited by 483 · see citing works
Self-citation
Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies
Cassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415 · see citing works
Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives
Khan, M. J., Ullah, A., & Basit, S. (2019) · The Application of Clinical Genetics · doi:10.2147/tacg.s200341 · Cited by 399 · see citing works
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362 · see citing works
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300 · see citing works
Identifying Children at Risk for Polycystic Ovary Syndrome
Rosenfield, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2012 · Cited by 288 · see citing works
Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
O’Reilly, M., TAYLOR, A. E. R., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 279 · see citing works
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262 · see citing works
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome
Barber, T. M., Wass, J. A. H., McCarthy, M. I., & Franks, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02764.x · Cited by 254 · see citing works
Diagnostic Criteria for Polycystic Ovary Syndrome: Pitfalls and Controversies
Lujan, M. E., Chizen, D. R., & Pierson, R. A. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32915-2 · Cited by 217 · see citing works
Polycystic ovary syndrome in adolescents
Franks, S. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.61 · Cited by 210 · see citing works
Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database
Kumarendran, B., O’Reilly, M. W., Manolopoulos, K. N., Toulis, K. A., Gokhale, K. M., Sitch, A. J., Wijeyaratne, C. N., Coomarasamy, A., Arlt, W., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002542 · Cited by 206 · see citing works
Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
Guastella, E., Longo, R. A., & Carmina, E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.014 · Cited by 205 · see citing works
Referral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome
Ezeh, U., Yildiz, B. O., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1295 · Cited by 193 · see citing works
Polycystic ovary syndrome throughout a woman’s life
Group of interest in Reproductive Endocrinology (GIER) of the Spanish Fertility Society (SEF), Bellver, J., Rodríguez-Tabernero, L., Robles, A., Muñoz, E., Martínez, F., Landeras, J., García-Velasco, J., Fontes, J., Álvarez, M., et al. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1047-7 · Cited by 180 · see citing works
Reproductive and Metabolic Phenotype of a Mouse Model of PCOS
van Houten, E. L. A. F., Kramer, P., McLuskey, A., Karels, B., Themmen, A. P. N., & Visser, J. A. (2012) · Endocrinology · doi:10.1210/en.2011-1754 · Cited by 190 · see citing works
Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility
Calcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183 · see citing works
Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys
Abbott, D. H., Tarantal, A. F., & Dumesic, D. A. (2009) · American Journal of Primatology · doi:10.1002/ajp.20679 · Cited by 177 · see citing works
Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis
Lizneva, D., Kirubakaran, R., Mykhalchenko, K., Suturina, L., Chernukha, G., Diamond, M. P., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1121 · Cited by 171 · see citing works
Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Müllerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism
Dewailly, D., Pigny, P., Soudan, B., Catteau-Jonard, S., Decanter, C., Poncelet, É., & Duhamel, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0334 · Cited by 155 · see citing works
Self-citation
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study
Panidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155 · see citing works
MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease
Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0124 · Cited by 154 · see citing works
Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause
Welt, C. K., & Carmina, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2375 · Cited by 148 · see citing works
Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large‐scale Chinese population
Zhang, H., Zhu, F., Xiong, J., Shi, X., & Fu, S. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02347.x · Cited by 139 · see citing works
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria
Goverde, A. J., van Koert, A. J. B., Eijkemans, M. J., Knauff, E. A. H., Westerveld, H. E., Fauser, B. C. J. M., & Broekmans, F. J. (2008) · Human Reproduction · doi:10.1093/humrep/den433 · Cited by 135 · see citing works
Criteria, phenotypes and prevalence of polycystic ovary syndrome
Belenkaia, L. V., Лазарева, Л. М., Walker, W., Lizneva, D., & Сутурина, Л. В. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04404-6 · Cited by 133 · see citing works
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
Chae, S. J., Kim, J. J., Choi, Y. M., Hwang, K. R., Jee, B. C., Ku, S., Suh, C. S., Kim, S. H., Kim, J. G., & Moon, S. Y. (2008) · Human Reproduction · doi:10.1093/humrep/den239 · Cited by 127 · see citing works
Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization
Zhu, T., & Goodarzi, M. O. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab757 · Cited by 126 · see citing works
Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
Karrer-Voegeli, S., Rey, F., Reymond, M. J., Meuwly, J., Gaillard, R. C., & Gómez, F. (2009) · Medicine · doi:10.1097/md.0b013e3181946a2c · Cited by 125 · see citing works
Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective
Pasquali, R., Zanotti, L., Fanelli, F., Mezzullo, M., Fazzini, A., Labate, A. M. M., Repaci, A., Ribichini, D., & Gambineri, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4009 · Cited by 112 · see citing works
Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria
Kauffman, R. P., Baker, T. E., Baker, V. M., DiMarino, P., & Castracane, V. D. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.037 · Cited by 111 · see citing works
Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
Lerchbaum, E., Schwetz, V., Rabe, T., Giuliani, A., & Obermayer-Pietsch, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108263 · Cited by 110 · see citing works
Diagnostic criteria for PCOS: Is there a need for a rethink?
Dewailly, D. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.03.009 · Cited by 103 · see citing works
Self-citation
Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)
Tan, S., Scherag, A., Janssen, O. E., Hahn, S., Lahner, H., Dietz, T., Scherag, S., Grallert, H., Vogel, C. I. G., Kimmig, R., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-12 · Cited by 102 · see citing works
Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
Iervolino, M., Lepore, E., Forte, G., Laganà, A. S., Buzzaccarini, G., & Unfer, V. (2021) · Nutrients · doi:10.3390/nu13051677 · Cited by 98 · see citing works
Polycystic Ovary Syndrome in the Pediatric Population
Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 96 · see citing works
Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS)
Shahid, R., Iahtisham‐Ul‐Haq, Mahnoor, Awan, K. A., Iqbal, M. J., Munir, H., & Saeed, I. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14117 · Cited by 89 · see citing works
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction
Józkowiak, M., Piotrowska‐Kempisty, H., Kobylarek, D., Gorska, N., Mozdziak, P. E., Kempisty, B., Rachoń, D., & Spaczyński, R. (2022) · Cells · doi:10.3390/cells12010174 · Cited by 90 · see citing works
Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome
Głuszak, O., Stopińska-Głuszak, U., Glinicki, P., Kapuścińska, R., Snochowska, H., Zgliczyński, W., & Dębski, R. (2012) · ISRN Endocrinology · doi:10.5402/2012/569862 · Cited by 87 · see citing works
Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome
Fraissinet, A., Robin, G., Pigny, P., Lefebvre, T., Catteau-Jonard, S., & Dewailly, D. (2017) · Human Reproduction · doi:10.1093/humrep/dex239 · Cited by 82 · see citing works
Self-citation
A case–control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
Jamil, A. S., Alalaf, S., Al-Tawil, N. G., & Al‐Shawaf, T. (2015) · Reproductive Health · doi:10.1186/1742-4755-12-7 · Cited by 80 · see citing works
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
Catteau-Jonard, S., Pigny, P., Reyss, A.-C., Decanter, C., Poncelet, É., & Dewailly, D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0868 · Cited by 78 · see citing works
Self-citation
Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the rotterdam criteria
Jamil, A. S., Alalaf, S. K., Al-Tawil, N. G., & Al-Shawaf, T. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3889-5 · Cited by 73 · see citing works
Serum Anti-Mullerian Hormone Concentrations Are Elevated in Oligomenorrheic Girls without Evidence of Hyperandrogenism
Park, A. S., Lawson, M. A., Chuan, S. S., Oberfield, S. E., Hoeger, K. M., Witchel, S. F., & Chang, R. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2106 · Cited by 77 · see citing works
Prevalence of polycystic ovary syndrome in European countries and USA: A systematic review and meta-analysis
Chiaffarino, F., Cipriani, S., Dalmartello, M., Ricci, E. D., Esposito, G., Fedele, F., Vecchia, C. L., Negri, E., & Parazzini, F. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.10.020 · Cited by 75 · see citing works
The Polycystic Ovary Syndrome and recent human evolution
Corbett, S., & Morin-Papunen, L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.001 · Cited by 68 · see citing works
Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
Yilmaz, M., İsaoğlu, Ü., Delibaş, İ. B., & Kadanalı, S. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2010.01478.x · Cited by 71 · see citing works
Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population
Pehlivanov, B. K., & Orbetzova, M. M. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701536246 · Cited by 70 · see citing works
Polycystic Ovary-Like Abnormalities (PCO-L) in Women with Functional Hypothalamic Amenorrhea
Robin, G., Gallo, C., Catteau-Jonard, S., Maunoury-Lefebvre, C., Pigny, P., Duhamel, A., & Dewailly, D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1836 · Cited by 69 · see citing works
Self-citation
Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
Nautiyal, H., Imam, S. S., Alshehri, S., Ghoneim, M. M., Afzal, M., Alzarea, S. I., Güven, E., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030540 · Cited by 68 · see citing works
Not all women diagnosed with PCOS share the same cardiovascular risk profiles
Jovanovic, V. P., Carmina, E., & Løbo, R. A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.021 · Cited by 68 · see citing works
The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome
Alebić, M. Š., Stojanović, N., Duhamel, A., & Dewailly, D. (2015) · Human Reproduction · doi:10.1093/humrep/dev131 · Cited by 67 · see citing works
Self-citation
Polycystic ovary syndrome (PCOS)
Dewailly, D., Hiéronimus, S., Mirakian, P., & Hugues, J. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.12.003 · Cited by 67 · see citing works
Self-citation
Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
Ethel Codner, D., Íñiguez, G., Villarroel, C., López, P. V., Néstor Soto, I., Sir‐Petermann, T., CASSORLA, F. G., & Rey, R. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1252 · Cited by 65 · see citing works
Phenotype and genotype of polycystic ovary syndrome in Asia: Ethnic differences
Kim, J., & Choi, Y. M. (2019) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14132 · Cited by 62 · see citing works
Polycystic Ovary Syndrome in the Adolescent
Pfeifer, S. M., & Kives, S. L. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2008.12.004 · Cited by 60 · see citing works
11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome
Yoshida, T., Matsuzaki, T., Miyado, M., Saito, K., Iwasa, T., Matsubara, Y., Ogata, T., Irahara, M., & Fukami, M. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0212 · Cited by 59 · see citing works
Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age
de Medeiros, S. F., Yamamoto, M. M. W., de Medeiros, M. A. S., Barbosa, B. B., Soares, J. M., & Baracat, E. C. (2020) · Endocrine Connections · doi:10.1530/ec-19-0496 · Cited by 57 · see citing works
Long non-coding RNA H19 is associated with polycystic ovary syndrome in Chinese women: a preliminary study
Qin, L., Huang, C., Yan, X., Wang, Y., Li, Z., & Wei, X. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0004 · Cited by 57 · see citing works
Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome
Krentowska, A., & Kowalska, I. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3464 · Cited by 56 · see citing works
Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome
Kim, J., Hwang, K. R., Choi, Y. M., Moon, S. Y., Chae, S. J., Park, C. W., Kim, H. O., Choi, D. S., Kwon, H. C., Kang, B. M., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.01.049 · Cited by 56 · see citing works
The excess in 2–5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome
Dewailly, D., Catteau-Jonard, S., Reyss, A.-C., Maunoury-Lefebvre, C., Poncelet, É., & Pigny, P. (2007) · Human Reproduction · doi:10.1093/humrep/dem060 · Cited by 55 · see citing works
Self-citation
Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity
Calcaterra, V., Rossi, V., Massini, G., Casini, F., Zuccotti, G., & Fabiano, V. (2023) · Nutrients · doi:10.3390/nu15143144 · Cited by 54 · see citing works
Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes
Mumm, H., Jensen, D. M., Sørensen, J. A., Andersen, L. L. T., Ravn, P., Andersen, M., & Glintborg, D. (2014) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12545 · Cited by 54 · see citing works
Role of the CAG Repeat Polymorphism of the Androgen Receptor Gene in Polycystic Ovary Syndrome (PCOS)
Schüring, A. N., Welp, A., Gromoll, J., Zitzmann, M., Sonntag, B., Nieschlag, E., Greb, R. R., & Kiesel, L. (2011) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0031-1291343 · Cited by 53 · see citing works
Identification of subjects with polycystic ovary syndrome using electronic health records
Castro, V., Shen, Y., Yu, S., Finan, S., Pau, C. T., Gainer, V., Keefe, C. C., Savova, G., Murphy, S. N., Cai, T., et al. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0115-z · Cited by 51 · see citing works
New perspectives on the definition and management of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0832-1 · Cited by 51 · see citing works
Androgen Receptor Coregulator CTBP1-AS Is Associated With Polycystic Ovary Syndrome in Chinese Women: A Preliminary Study
Liu, Z., Hao, C., Song, D., Zhang, N., Bao, H., & Qu, Q. (2015) · Reproductive Sciences · doi:10.1177/1933719114565037 · Cited by 47 · see citing works
Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes
Cela, V., Obino, M. E. R., Alberga, Y., Pinelli, S., Sergiampietri, C., Casarosa, E., Simi, G., Papini, F., & Artini, P. G. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1412429 · Cited by 47 · see citing works
Genetics of Polycystic Ovary Syndrome
Welt, C. K. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.006 · Cited by 43 · see citing works
The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism
de Melo, A. S., Vieira, C. S., Romano, L. G. M., Ferriani, R. A., & Navarro, P. A. (2011) · Reproductive Sciences · doi:10.1177/1933719111414205 · Cited by 43 · see citing works
Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention
Dietz de Loos, A. L. P., Jiskoot, G., Timman, R., Beerthuizen, A., Busschbach, J. J. V., & Laven, J. S. E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.05.008 · Cited by 39 · see citing works
When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
Franks, S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03934.x · Cited by 39 · see citing works
Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females
Guraya, S. (2013) · Journal of Microscopy and Ultrastructure · doi:10.1016/j.jmau.2013.06.002 · Cited by 39 · see citing works
A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders
Vagios, S., James, K. E., Sacha, C. R., Hsu, J. Y., Dimitriadis, I., Bormann, C. L., & Souter, I. C. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.07.023 · Cited by 39 · see citing works
Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome
Sørensen, A. E., Udesen, P. B., Maciag, G. J., Geiger, J., Saliani, N., Januszewski, A. S., Jiang, G., Ronald, C. W., Hardikar, A. A., Wissing, M. L., et al. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00242 · Cited by 39 · see citing works
LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea
Hendriks, M. L., Brouwer, J., Hompes, P. G. A., Homburg, R., & Lambalk, C. B. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60140-x · Cited by 34 · see citing works
Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women
Dadachanji, R., Patil, A. D., Joshi, B. N., & Mukherjee, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246862 · Cited by 34 · see citing works
Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome
Yang, Z., Zhou, W., Zhou, C., Zhou, Y.-Z., Liu, X., Ding, G., Hu, Y., Pan, J., Sheng, J., Jin, L., et al. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105806 · Cited by 33 · see citing works
The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS.
Băculescu, N. (2013) · Europe PMC (PubMed Central) · Cited by 32 · see citing works
Role of Granulosa Cell Dysfunction in Women Infertility Associated with Polycystic Ovary Syndrome and Obesity
Chauvin, S. (2025) · Biomolecules · doi:10.3390/biom15070923 · Cited by 35 · see citing works
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes
Romualdi, D., Florio, C. D., Tagliaferri, V., Cicco, S. D., Gagliano, D., Immediata, V., Lanzone, A., & Guido, M. (2015) · Reproductive Sciences · doi:10.1177/1933719115611751 · Cited by 29 · see citing works
Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS
Jarrett, B. Y., & Lujan, M. E. (2016) · Reproduction · doi:10.1530/rep-16-0385 · Cited by 29 · see citing works
The PCOS Patients differ in Lipid Profile According to their Phenotypes
Spałkowska, M., Mrozińska, S., Gałuszka-Bednarczyk, A., Gosztyła, K., Przywara, A., Guzik, J., Janeczko, M., Milewicz, T., & Wojas‐Pelc, A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-121264 · Cited by 28 · see citing works
Polycystic Ovary Syndrome
Carmina, E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-864-5_4 · Cited by 28 · see citing works
Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea
Carmina, E., Fruzzetti, F., & Lobo, R. A. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.055 · Cited by 27 · see citing works
Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology
Dumont, A., Dewailly, D., Plouvier, P., Catteau-Jonard, S., & Robin, G. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1191462 · Cited by 23 · see citing works
Self-citation
Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.
Vaggopoulos, V., Trakakis, E., Chrelias, C. G., Panagopoulos, P., Basios, G., MAKRIDIMA, S., Sioulas, V. D., SIMEONIDES, G., Labos, G., Boutati, E. I., et al. (2013) · PubMed · doi:10.3275/8771 · Cited by 23 · see citing works

Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
Baldani, D. P., Škrgatić, L., Šimunić, V., Zlopaša, G., Čanić, T., & Trgovčić, I. (2013) · PubMed · Cited by 25 · see citing works
Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
Yilmaz, M., İsaoğlu, Ü., Delibaş, İ. B., & Kadanalı, S. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2010.01478.x · Cited by 71 · see citing works
Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population [Osobine različitih policističnih jajnika u Hrvatskoj dijagnosticiranih po Rotterdamskim kriterijima]
Pavičić Baldani, D., Škrgatić, L., Šimunić, V., Zlopaša, G., Čanić, T., & Trgovčić, I. (2013) · Repository of the Medical Faculty of the University of Zagreb (University of Zagreb)
Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large‐scale Chinese population
Zhang, H., Zhu, F., Xiong, J., Shi, X., & Fu, S. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02347.x · Cited by 139 · see citing works
Analysis on endocrine and metabolic features of different phenotypes of polycystic ovary syndrome patients
Li, F. (2016) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/29/5(sup)/05.10.2016/487/1735-1738 · Cited by 4 · see citing works

Authors: Dewailly, D., Catteau-Jonard, S., Reyss, A.-C., Leroy, M., & Pigny, P.
Affiliations: Centre Hospitalier Universitaire de Lille (FR)
Université de Lille (FR)
ORCID: Dewailly, Didier
Catteau-Jonard, Sophie
Pigny, Pascal
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2006-10
Volume: 91
Issue: 10
Pages: 3922-3927
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2006-1054
OpenAlex: W1969092794
Cited by: 198
References: 30
Citations by year: 2026: 2 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 12 · 2021: 12 · 2020: 5 · 2019: 8 · 2018: 11 · 2017: 8 · 2016: 18 · 2015: 15 · 2014: 7 · 2013: 13 · 2012: 9
FWCI: 13.76
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords: polycystic ovary syndrome, oligoanovulation, polycystic ovary, hyperandrogenism, PCOS phenotypes, Rotterdam criteria, serum testosterone, androstenedione, luteinizing hormone, follicle-stimulating hormone, sex hormone-binding globulin, waist circumference, metabolic abnormalities
MeSH terms: Adult, Androstenedione, Anovulation, Female, Follicle Stimulating Hormone, Humans, Luteinizing Hormone, Phenotype, Polycystic Ovary Syndrome, Sex Hormone-Binding Globulin, Testosterone, Body Mass Index, Hyperandrogenism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks